SDZNY:OTCMKTS
Sandoz
87,56 USD
arrow_upward
+1,97%(+1,69) 1G
14 ott, 10:42:20 GMT-4 · USD
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per SDZNY in corso…
Apertura
87,34 USD
Massimo
87,74 USD
Minimo
87,30 USD
Cap. mercato
32,24 Mld
Vol. medio
26,44K
Volume
9,10K
Max 52 sett.
94,15 USD
Min 52 sett.
60,40 USD
Azioni in circolazione
440,00 Mln
N. di dipendenti
20K
Apertura
87,34 USD
Massimo
87,74 USD
Minimo
87,30 USD
Cap. mercato
32,24 Mld
Vol. medio
26,44K
Volume
9,10K
Max 52 sett.
94,15 USD
Min 52 sett.
60,40 USD
Azioni in circolazione
440,00 Mln
N. di dipendenti
20K
Articoli giornalistici
Da fonti web e partner giornalistici
ad-hoc-news.de
·
12 minuti fa
Barclays keeps CHF 93.00 target for Sandoz stock
ad-hoc-news.de
·
4 ore fa
Sandoz agrees to end three Crexont suits and Sandoz stock costs EUR 77.51
ad-hoc-news.de
·
8 ore fa
Sandoz patent dispute ends: Sandoz stock pre-market at EUR 76.85
Yahoo Finance Australia
·
1 giorno fa
NBIX vs. SDZNY: Which Stock Should Value Investors Buy Now?
Profilo
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
Informazioni su Sandoz